Managing epilepsy in pregnant women is challenging and requires specialised knowledge about the potential teratogenicity of antiseizure medications (ASMs), their interactions with hormone contraceptives, and their effects on folate metabolism and pregnancy outcomes. 

About half of pregnancies in women with epilepsy are unplanned due to interactions between ASMs and hormone ...